Outputs

  1. Publications
  2. Presentations

Publications

  • Barry, N., Francis, R. J., Ebert, M. A., Koh, E.-S., Rowshanfarzad, P., Hassan, G. M., Kendrick, J., Gan, H. K., Lee, S. T., Lau, E., Moffat, B. A., Fitt, G., Moore, A., Thomas, P., Pattison, D. A., Akhurst, T., Alipour, R., Thomas, E. L., Hsiao, E., Schembri, G. P., Lin, P., Ly, T., Yap, J., Kirkwood, I., Vallat, W., Khan, S., Krishna, D., Ngai, S., Yu, C., Beuzeville, S., Yeow, T. C., Bailey, D., Cook, O., Whitehead, A., Dykyj, R., Rossi, A., Grose, A., & Scott, A. M. (2023). Delineation and agreement of FET PET biological volumes in glioblastoma: results of the nuclear medicine credentialing program from the prospective, multi-centre trial evaluating FET PET In Glioblastoma (FIG) study—TROG 18.06. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06371-5
  • Koh, E. S., Gan, H. K., Senko, C., Francis, R. J., Ebert, M., Lee, S. T., Lau, E., Khasraw, M., Nowak, A. K., Bailey, D. L., Moffat, B. A., Fitt, G., Hicks, R. J., Coffey, R., Verhaak, R., Walsh, K. M., Barnes, E. H., De Abreu Lourenco, R., Rosenthal, M., Adda, L., Foroudi, F., Lasocki, A., Moore, A., Thomas, P. A., Roach, P., Back, M., Leonard, R., & Scott, A. M. (2023). [(18)F]-fluoroethyl-L-tyrosine (FET) in glioblastoma (FIG) TROG 18.06 study: protocol for a prospective, multicentre PET/CT trial. BMJ Open, 13(8), 10.1136/bmjopen-2022-071327
  • Kendrick, J., Francis, R. J., Hassan, G. M., Rowshanfarzad, P., Ong, J. S. L., McCarthy, M., Alexander, S., & Ebert, M. A. (2023). Prognostic utility of RECIP 1.0 with manual and AI-based segmentations in biochemically recurrent prostate cancer from [68Ga]Ga-PSMA-11 PET images. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-023-06382-2
  • Kendrick, J., Francis, R. J., Hassan, G. M., Rowshanfarzad, P., Ong, J. S. L., & Ebert, M. A. (2022). Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [(68)Ga]Ga-PSMA-11 PET/CT images. Eur J Nucl Med Mol Imaging, 50(1), 67-79. 10.1007/s00259-022-05927-1
  • Koh, E.-S., Francis, R. J., Ebert, M., Gan, H., Lee, S. T., Lau, E., Moore, A., Grose, A., Rossi, A., Ng, S. P., Yap, J., Ly, T., Lin, P., Pinkham, M. B., Ngai, S., Yu, C., Gorayski, P., Le, H., Kirkwood, I. D., Vallat, W., Syed, F., Krishna, D., Khan, S., Gill, S., Thomas, E., Back, M., Barnes, E. H., Moffat, B. A., Scott, F., Adda, L., Foroudi, F., Lourenco, R. D. A., Nowak, A. K., Bailey, D. L., & Scott, A. M. (2021). NIMG-49. A prospective, multi-centre trial of FET-PET in glioblastoma patients – the TROG 18.06 FIG study: key aspects of imaging and radiation oncology credentialing. Neuro-Oncology, 23(Supplement_6), vi140-vi140. 10.1093/neuonc/noab196.547
  • Kendrick, J., Francis, R., Hassan, G. M., Rowshanfarzad, P., Jeraj, R., Kasisi, C., Rusanov, B., & Ebert, M. (2021). Radiomics for Identification and Prediction in Metastatic Prostate Cancer: A Review of Studies. Front Oncol, 11, 771787. 10.3389/fonc.2021.771787
  • Ferjančič, P., Ebert, M. A., Francis, R., Nowak, A. K., & Jeraj, R. (2021). Repeatability of Quantitative 18F-FET PET in Glioblastoma. Biomed Phys Eng Express, 7(3). 10.1088/2057-1976/abfae9
  • Barry, N., Rowshanfarzad, P., Francis, R. J., Nowak, A. K., & Ebert, M. A. (2021). Repeatability of image features extracted from FET PET in application to post-surgical glioblastoma assessment. Physical and Engineering Sciences in Medicine, 44(4), 1131-1140. 10.1007/s13246-021-01049-4

Presentations

  • N Barry, RJ Francis, MA Ebert, E-S Koh, HK Gan, ST Lee, E Lau, BA Moffat, A Moore, M Back, B Chua, C Brighi, E Thomas, D Bailey, O Cook, A Whitehead, R Dykyj, A Rossi, A Grose, H Evans, AM Scott (2023) Quantifying interobserver agreement and variability: from the TROG 18.06 FIG (FET-PET in Glioblastoma) study credentialing program, TROG Cancer Research Annual Scientific Meeting, Adelaide SA
  • Mikaela Dell’Oro, Shasha Yeung, Martin A. Ebert, Roslyn J. Francis (2023) Artificial intelligence in medical imaging– industry collaboration enabling advanced analysis of disease burden in patients with metastatic prostate cancer to improve individualized treatment, Science on the Swan, Perth WA
  • Mikaela Dell’Oro, Shasha Yeung, Martin A. Ebert, Jeremy Ong, Mike McCarthy, Colin Tang, Timothy Perk, Roslyn J. Francis (2023) Automated assessment of lesion heterogeneity for metastatic prostate cancer patients using [68Ga]Ga-PSMA-11 PET/CT images, Australian and New Zealand Society of Nuclear Medicine, Adelaide, SA
  • Barry N, Ebert MA, Koh E-S, Dykjy R, Francis RJ, Gan H, Lee S-T, Lau E, Rossi A, Grose A, Evans H, Whitehead A, Cook O, Thomas E, Back M, Chua B, Moffat B, Brighi C, Bailey D, Scott AS (2023) Quantifying interobserver agreement and variability: from the TROG 18.06 FIG (FET-PET in Glioblastoma) study credentialing program, TROG Cancer Research ASM, Adelaide SA
  • Heidi Espedal, Girish Dwivedi, Sheeraz Mohd, Tammy Hagan, Joanne Watts, Benjamin Bartlett, Martin Ebert, Shiprah Verma, Roslyn J. Francis (2023) 18F-FDG PET detects persistent arterial inflammation following symptomatic COVID-19 infection, Australian and New Zealand Society of Nuclear Medicine, Adelaide, SA
  • Dr Mikaela Dell’Oro, A/Prof Roslyn J. Francis, A/Prof Elin S. Gray, Dr Daniel Huff, Dr Timothy G. Perk, Dr Rajkumar Munian-Govindan, Dr Shasha Yeung, Prof Martin A. Ebert, Prof Michael Millward (2023) Quantitative features derived from 18F-FDG PET/CT predict immunotherapy related toxicities for metastatic melanoma patients from baseline, ASCO, Chicago IL USA
  • Barry, N, Francis, R.J, Ebert, M.A., Koh, E-S., Gan, H.K.., Lee, S.T., Lau, E, Moffat, B.A., Fitt,G., Moore, A., Thomas, P., Pattison, D., Akhurst, T., Alipour, R., Thomas, E., Hsaio, E., Schembri, G.P., Lin, P., Ly, T., Yap, J., Kirkwood, I., Vallat, W. ,Khan, S., Krishna, D., Ngai, S., Yu, C., Beuzeville, S., Yeow, J., Bailey, D., Cook, O., Whitehead, A., Dykyj, R., Rossi, A., Grose, A., Scott, A.M (2023) Multi-observer delineation and agreement of FET-PET biological volumes in glioblastoma: results from the Nuclear Medicine credentialing program from the prospective, multi-centre trial evaluating FET-PET In Glioblastoma (FIG) Study – TROG 18.06, Australian and New Zealand Society of Nuclear Medicine, Adelaide, SA
  • Koh E, Moore A, Francis R, Ebert M, Gan H, Lee S, Lau E, Rossi A, Grose A, Ng S, Barnes E, Moffatt B, Scott F, Adda L, Foroudi F, De Abreu Lourenco R, Nowak A, Bailey D, Back M, Scott A (2022) A prospective, multi-centre trial of FET-PET In Glioblastoma (FIG) patients (TROG 18.06): Nuclear Medicine and Radiation Oncology credentialing program results. Journal of Medical Imaging and Radiation Oncology, 66(Suppl. S1), 134 Awarded the Chris Atkinson Award – Best Scientific Paper Presentation in Radiation Oncology, and the Elekta Award – Advances in the Use of Technology in Radiation Therapy – Best Scientific Paper
  • Kendrick J, Francis R, Hassan G, Rowshanfarzad P, Ong J, Ebert MA (2022) Automatic Metastatic Prostate Cancer Disease Burden Quantification in 68Ga-PSMA PET/CT Images, Engineering and Physical Sciences in Medicine, Adelaide SA
  • A.M. Scott, R. Francis, M. Ebert, H.K. Gan, S.T. Lee, E. Lau, A. Moore, E. BarnesB. Moffatt, F.E. Scott, L. Adda, F. Foroudi, R. De Abreu Lourenco, A. Nowak, D. Bailey, E-S. Koh (2021) A prospective, multi-centre trial of FET PET in Glioblastoma patients – the FIG Study, European Association for Nuclear Medicine